Novo Nordisk A/S Class BEigentümerstruktur
| Preis (-) | 52W Hoch | 52W Tief |
| - DKK | - DKK | - DKK |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - DKK | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 2.414.099.968 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Novo Nordisk A/S Class B
Mitarbeiter 59.337
Handelsplatz LSE
Ticker Symbol 0QIU
IPO Datum -
Adresse Novo Allé 1, Bagsvaerd, Denmark, 2880
Webseite https://www.novonordisk.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Lars Fruergaard Jorgensen | Pres, CEO & Member of Management Board |
| 2 | Mr. Karsten Munk Knudsen | Exec. VP, CFO & Member of the Management Board |
| 3 | Mr. Henrik Ehlers Wulff | Exec. VP, Head of Product Supply, Quality & IT and Member of the Management Board |
| 4 | Ms. Camilla Sylvest | Exec. VP, Head of Commercial Strategy & Corp. Affairs and Member of the Management Board |
| 5 | Dr. Martin Holst Lange | Exec. VP, Head of Devel. & Member of the Management Board |
| 6 | Ms. Monique Carter | Exec. VP, Head of People & Organisation and Member of Management Board |
| 7 | Dr. Marcus Schindler Ph.D. | EVP, Head of Research & Early Devel., Chief Scientific Officer & Member of the Management Board |
| 8 | Mr. Maziar Mike Doustdar | Exec. VP, Head of International Operations & Member of the Management Board |
| 9 | Mr. Douglas J. Langa | Exec. VP, Head of North America Operations & Member of Management Board |
| 10 | Mr. Ludovic Helfgott | Exec. VP, Head of Rare Disease & Member of Management Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.